Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SToP-BPD study
2010-023777-19Phase 3
- Sponsor
- Academic Medical Center
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrocortisone in bronchopulmonary dysplasia (BPD), sponsored by Academic Medical Center. Primary endpoints: BPD-free survival at 36 weeks PMA, Bronchopulmonary dysplasia at 36 weeks PMA and 2 more.
02
Drugs
hydrocortisone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on 2010-023777-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023777-19.